Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 1/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.56 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | S100A4 | P26447 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.42 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.42 |
| ▸ | ABAT | P80404 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22918190 | 0.87 | ERN1 (0.65) | ERN1TDP1GPR35KMT2ATSHR | |
| SCHEMBL1619153 | 0.87 | ERN1 (0.50) | ERN1TDP1GPR35KMT2ATSHR | |
| SCHEMBL31339796 | 0.87 | ERN1 (0.50) | ERN1TDP1GPR35KMT2ATSHR | |
| SCHEMBL3050110 | 0.86 | GPR35 (0.58) | ERN1TDP1GPR35KMT2ATSHR | |
| SCHEMBL103575 | 0.86 | TDP1 (0.59) | ERN1TDP1GPR35KMT2ATSHR | |
| SCHEMBL101394 | 0.86 | ERN1 (0.49) | ERN1TDP1GPR35KMT2ATSHR | |
| SCHEMBL9141067 | 0.86 | ERN1 (0.49) | ERN1TDP1GPR35KMT2ATSHR | |
| SCHEMBL13982712 | 0.86 | ERN1 (0.49) | ERN1TDP1GPR35KMT2ATSHR | |
| SCHEMBL700297 | 0.86 | TSHR (0.60) | ERN1TDP1GPR35KMT2ATSHR | |
| SCHEMBL18816145 | 0.84 | TDP1 (0.48) | ERN1TDP1GPR35KMT2ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 637 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220257483-A1 | INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL | HENKEL AG & CO. KGAA (DE) | 2022-08-18 | — | — | US | claimed |
| EP-4003286-A1 | INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL | Henkel AG & Co. KGaA (DE) | 2022-06-01 | — | — | EP | claimed |
| CN-114173750-A | Improving the stability of agents for treating keratin materials | 汉高股份有限及两合公司 | 2022-03-11 | — | — | CN | claimed |
| WO-2021013420-A1 | INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL | HENKEL AG & CO. KGAA (DE) | 2021-01-28 | — | — | WO | claimed |
| US-9018409-B2 | Process for functionalization of unsaturated compounds | MEURICE R&D ASBL (BE) | 2015-04-28 | — | — | US | claimed |
| EP-2632886-A1 | PROCESS FOR FUNCTIONALIZATION OF UNSATURATED COMPOUNDS | Meurice R&D ASBL (BE) | 2013-09-04 | — | — | EP | claimed |
| CN-102229614-B | Method for synthesizing 9-aminocamptothecin | HENAN DONGTAI PHARM CO LTD | 2013-08-21 | — | — | CN | claimed |
| CN-102229615-B | Method for synthesizing 9-nitrocamptothecin | HENAN DONGTAI PHARM CO LTD | 2013-08-21 | — | — | CN | claimed |
| US-20130211033-A1 | PROCESS FOR FUNCTIONALIZATION OF UNSATURATED COMPOUNDS | MEURICE R&D ASBL (BE) | 2013-08-15 | — | — | US | claimed |
| EP-1778176-B1 | COMPOSITION FOR COLOURING KERATIN-CONTAINING FIBRES | HENKEL AG & CO KGAA (DE) | 2012-07-25 | — | — | EP | claimed |
| US-6458168-B1 | Hair dyeing method using an aliphatic cationic amine and compound chosen from an aldehyde, a ketone, a quinone, a di-imino-isoindoline, and a 3-aminoisoindolone derivative | L'OREAL S.A. (FR) | 2002-10-01 | — | — | US | claimed |
| US-6451067-B1 | HAIR DYE MIXTURE | L'OREAL S.A. (FR) | 2002-09-17 | — | — | US | claimed |
| WO-2000038634-A1 | AGENT FOR DYING KERATIN FIBERS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2000-07-06 | — | — | WO | claimed |
| EP-0650511-A4 | PHOTOTRANSCHROMIC INK. | XYTRONYX INC (US) | 1996-04-10 | — | — | EP | claimed |
| EP-0650511-A1 | PHOTOTRANSCHROMIC INK | XYTRONYX, INC. (US) | 1995-05-03 | — | — | EP | claimed |
| US-5296275-A | Water soluble nonionic resin carrier, a light sensitive compound which colors in response to protons, wetting agents, thickeners and flow aids | XYTRONYX, INC. (US) | 1994-03-22 | — | — | US | claimed |
| WO-1994001503-A1 | PHOTOTRANSCHROMIC INK | XYTRONYX, INC. (US) | 1994-01-20 | — | — | WO | claimed |
| EP-0290750-A2 | Systems for the visualization of exposure to ultraviolet radiation and for the utilization of ultraviolet radiation to effect color changes | XYTRONYX, INC. (US) | 1988-11-17 | — | — | EP | claimed |
| WO-1988007222-A1 | SYSTEMS FOR THE VISUALIZATION OF EXPOSURE TO ULTRAVIOLET RADIATION AND FOR THE UTILIZATION OF ULTRAVIOLET RADIATION TO EFFECT COLOR CHANGES | XYTRONYX, INC. (US) | 1988-09-22 | — | — | WO | claimed |
| US-4042558-A | Filled polymerization products based on carbodiimide copolymers | BAYER AKTIENGESELLSCHAFT (DT) | 1977-08-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220257483-A1 | INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL | KRT18, VIM, CDH1 | ERN1 2313/4885TDP1 3850/4885GPR35 4257/4885 |
| US-20130211033-A1 | PROCESS FOR FUNCTIONALIZATION OF UNSATURATED COMPOUNDS | F10, RPP30, PUF60 | ERN1 1728/4885TDP1 3843/4885GPR35 963/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.